Skip to main content

and
  1. Article

    Open Access

    Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

    The M72/AS01E tuberculosis vaccine showed 50% (95%CI: 2–74%) efficacy in a phase 2B trial in preventing active pulmonary tuberculosis disease, but potential cost-effectiveness of adolescent immunisation is unknow...

    Rebecca C. Harris, Matthew Quaife, Chathika Weerasuriya in Nature Communications (2022)